100% satisfaction guarantee Immediately available after payment Both online and in PDF No strings attached
logo-home
NR546 WEEK 6 2024 ACTUAL EXAM COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND NEW!!. $19.99   Add to cart

Exam (elaborations)

NR546 WEEK 6 2024 ACTUAL EXAM COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND NEW!!.

 5 views  0 purchase
  • Course
  • NR546
  • Institution
  • NR546

NR546 WEEK 6 2024 ACTUAL EXAM COMPLETE QUESTIONS AND CORRECT DETAILED ANSWERS (VERIFIED ANSWERS) |ALREADY GRADED A+||BRAND NEW!!.

Preview 4 out of 31  pages

  • October 31, 2024
  • 31
  • 2024/2025
  • Exam (elaborations)
  • Questions & answers
  • NR546
  • NR546
avatar-seller
Americannursingaassociation
NR546 WEEK 6 2024 ACTUAL EXAM COMPLETE
QUESTIONS AND CORRECT DETAILED ANSWERS
(VERIFIED ANSWERS) |ALREADY GRADED
A+||BRAND NEW!!.


Substance Use Disorder - ANSWEROccurs when the recurrent use of a substance, such
as alcohol or drugs, causes clinically significant impairment, including health problems,
disability, or failure to meet responsibilities at home, work, or school.


When does drug use typically begin? - ANSWERAdolescence


Common Comorbidities of substance use disorder - ANSWERAnxiety disorders
depression
bipolar disorder
psychotic illness
borderline personality disorder
antisocial personality disorder


Neurological basis: Genetic factors of SUD - ANSWER40-60% of a client's vulnerability to
substance use disorders may be attributed to genetic factors


Vulnerability involves complex interactions between multiple genetic factors/.


Genetic involvement may impact an individual's experience of a drug as pleasurable or
not or how long a drug remains in the body.


Epigenetic factors in SUD` - ANSWERinfluence whether genes associated with substance
use disorder are activated


Neurological Basis: Neuroanatomy in SUD - ANSWERBrain circuits that mediate reward,
impulse control, decision making, learning, and emotions play a role in substance use
disorder.

,Mesolimbic Dopamine pathway in SUD - ANSWERhas been identified as the key pathway
that mediates reward.


Connects the ventral tegmental area of the midbrain to the ventral striatum of the basal
ganglia.


The pathway begins in the ventral tegmental area (VTA) and connects to the ventral
striatum/nucleus


Neurobiological Basis: Neural Networks - ANSWERMesolimbic pathway is most
associated with reward. Drugs and alcohol act directly on brain receptors leading to a
release of dopamine.


As substance use increases, brain circuits adapt by reducing sensitivity to dopamine,
leading to tolerance and the need to increase use of a substance to achieve the same
high.


Neurological Basis: Neural Signaling - ANSWERDopamine is responsible for regulating
the brain's motivation, pleasure, and reward center.


Dopamine is release in response to natural pleasurable activities or situations such as
achieving an accomplishment, enjoying a good meal. or participating in an athletic
activity. Addictive drugs cause a surge of dopamine in the ventral striatum or nucleus
accumbens.
Repeated use can lead to changes in brain circuitry leading to craving, addiction,
dependence, withdrawal.


What neurotransmitter is the target when treating SUD? - ANSWERDopamine.


Tolerance - ANSWERWith repeated ingestion of a drug, the drug shows decreased effect.
Increasing doses are required to achieve the effects noted with the original
administration

,Dependence - ANSWERState of adaption produced with repeated administration of
certain drugs so that physical symptoms occur when the drug is discontinued abruptly.


Addiction - ANSWERA change in behavior caused by biochemical changes in the brain
after continued substance use characterized by preoccupation with and repeated use of
a substance despite negative outcomes.


Withdrawal - ANSWERPhysiological and psychological reactions that occur when the
use of a substance is stopped abruptly.


Intoxication - ANSWERCondition following the ingestion of a substance resulting in
changes in level of consciousness, cognition, perception, judgement, and behavior.


Treatment - ANSWERThe PMHNP must ascertain what substance the client is using, how
much and how often the substance is used, and when the substance was last ingested to
determine the most appropriate course of treatment.


Treatment is different when a client is actively using vs during withdrawal, following
detoxification, and abstinence.


Tolerance and dependence impact treatment decisions, sometimes necessitating
increased medication dosing.


Medication Assisted Therapy (MAT) - ANSWERclients use prescription medications as
part of a treatment plan for SUD. Substitutes the drug of abuse for the prescribed
medication that targets the same receptor as the preferred substance.


Can reduce cravings, improve relapse rates, reduce mortality from overdose, and
increase the likelihood of abstinence either alone or in combination with with
psychosocial interventions. Most prescribed for opioid use disorder but may also be
used for clients with alcohol or tobacco use disorder.


Goals of MAT - ANSWERImproved Survival
Improved treatment retention

, Decreased illegal activity
Increased Quality of Life
Improved birth outcomes in people who use substance while pregnant
Reduced HIV and Hep B&C infections


Impulsive/Compulsive Disorders - ANSWEROther mental health disorders shar similar
neurobiological characteristics with substance use disorders.


Pharmacological management for Obesity - ANSWERPhentermine or
phentermine/topiramate


Bupropion or bupropion/naltrexone


lorcaserin


zonisamide


Pharmacological management for Anorexia Nervosa - ANSWEROlanzapine may lead to
modest weight gain


Pharmacological management for Bulimia Nervosa - ANSWERHigh dose fluoxetine


Pharmacological Management for Binges Eating Disorders - ANSWERLisdexamfetamine


Topiramate


Bupropion


What medication do you avoid in individuals with anorexia nervosa and bulimia nervosa
and why? - ANSWERAvoid bupropion as it lowers the seizure threshold in these patients
putting them at risk for new onset seizures.


Opioid Use Disorder - ANSWERChronic Use of opioids that causes clinically significant
distress or impairment

The benefits of buying summaries with Stuvia:

Guaranteed quality through customer reviews

Guaranteed quality through customer reviews

Stuvia customers have reviewed more than 700,000 summaries. This how you know that you are buying the best documents.

Quick and easy check-out

Quick and easy check-out

You can quickly pay through credit card or Stuvia-credit for the summaries. There is no membership needed.

Focus on what matters

Focus on what matters

Your fellow students write the study notes themselves, which is why the documents are always reliable and up-to-date. This ensures you quickly get to the core!

Frequently asked questions

What do I get when I buy this document?

You get a PDF, available immediately after your purchase. The purchased document is accessible anytime, anywhere and indefinitely through your profile.

Satisfaction guarantee: how does it work?

Our satisfaction guarantee ensures that you always find a study document that suits you well. You fill out a form, and our customer service team takes care of the rest.

Who am I buying these notes from?

Stuvia is a marketplace, so you are not buying this document from us, but from seller Americannursingaassociation. Stuvia facilitates payment to the seller.

Will I be stuck with a subscription?

No, you only buy these notes for $19.99. You're not tied to anything after your purchase.

Can Stuvia be trusted?

4.6 stars on Google & Trustpilot (+1000 reviews)

67866 documents were sold in the last 30 days

Founded in 2010, the go-to place to buy study notes for 14 years now

Start selling
$19.99
  • (0)
  Add to cart